12-753475-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018979.4(WNK1):​c.-91T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 1,561,778 control chromosomes in the GnomAD database, including 157,617 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 13399 hom., cov: 32)
Exomes 𝑓: 0.45 ( 144218 hom. )

Consequence

WNK1
NM_018979.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.835

Publications

11 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 12-753475-T-G is Benign according to our data. Variant chr12-753475-T-G is described in ClinVar as [Benign]. Clinvar id is 310533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.461 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.-91T>G 5_prime_UTR_variant Exon 1 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.-91T>G 5_prime_UTR_variant Exon 1 of 28 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.-91T>G 5_prime_UTR_variant Exon 1 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.-91T>G 5_prime_UTR_variant Exon 1 of 28 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.409
AC:
62068
AN:
151902
Hom.:
13391
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.277
Gnomad AMI
AF:
0.538
Gnomad AMR
AF:
0.453
Gnomad ASJ
AF:
0.407
Gnomad EAS
AF:
0.319
Gnomad SAS
AF:
0.326
Gnomad FIN
AF:
0.568
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.411
GnomAD4 exome
AF:
0.448
AC:
631840
AN:
1409762
Hom.:
144218
Cov.:
27
AF XY:
0.446
AC XY:
311153
AN XY:
698012
show subpopulations
African (AFR)
AF:
0.271
AC:
8670
AN:
32030
American (AMR)
AF:
0.481
AC:
19806
AN:
41188
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
10384
AN:
25502
East Asian (EAS)
AF:
0.321
AC:
11981
AN:
37372
South Asian (SAS)
AF:
0.349
AC:
28774
AN:
82538
European-Finnish (FIN)
AF:
0.558
AC:
26562
AN:
47586
Middle Eastern (MID)
AF:
0.389
AC:
1582
AN:
4072
European-Non Finnish (NFE)
AF:
0.462
AC:
499115
AN:
1081360
Other (OTH)
AF:
0.430
AC:
24966
AN:
58114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
18062
36123
54185
72246
90308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14820
29640
44460
59280
74100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.409
AC:
62100
AN:
152016
Hom.:
13399
Cov.:
32
AF XY:
0.413
AC XY:
30677
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.277
AC:
11501
AN:
41484
American (AMR)
AF:
0.453
AC:
6921
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
1411
AN:
3470
East Asian (EAS)
AF:
0.319
AC:
1643
AN:
5146
South Asian (SAS)
AF:
0.327
AC:
1574
AN:
4818
European-Finnish (FIN)
AF:
0.568
AC:
6012
AN:
10576
Middle Eastern (MID)
AF:
0.346
AC:
101
AN:
292
European-Non Finnish (NFE)
AF:
0.465
AC:
31589
AN:
67932
Other (OTH)
AF:
0.407
AC:
857
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1872
3744
5615
7487
9359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.311
Hom.:
870
Bravo
AF:
0.397
Asia WGS
AF:
0.290
AC:
1009
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Pseudohypoaldosteronism type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
5.6
DANN
Benign
0.73
PhyloP100
-0.83
PromoterAI
-0.036
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3088353; hg19: chr12-862641; COSMIC: COSV60037615; API